Research Cell
Fostering Scientific Inquiry & Innovation
Fostering a culture of scientific inquiry, evidence-based practice, and pharmaceutical innovation to address real-world healthcare challenges.
About Our Research Cell
The Research Cell at Abasaheb Kakade College of Pharmacy was established with the vision to promote scientific investigation and pharmaceutical research among students and faculty. The cell serves as the nucleus of all research-related activities within the institution.
We encourage students and faculty to engage in research that creates meaningful contributions to pharmaceutical science, healthcare, and the community at large. Our research encompasses areas ranging from traditional herbal medicines to modern drug delivery systems.
Explore Research Areas
Featured Research Highlights
The present study utilizes the principle of rheological synergism between hydrophilic polymers in development of pharmaceutical formulations, more specifically to develop and evaluate delayed release matrix tablet using polymer blends. Methocarbamol is an FDA approved centrally acting skeletal muscle relaxant. It works by calming overactive nerves in body, which helps muscles to get relaxed but its mechanism of action is not well defined and its effects are measured mainly by subjective responses. Half-life of Methocarbamol is short so it is necessary to prolong drug action, hence it was decided to develop matrix tablets as desired dosage form. HPMC, SCMC, its blends and marketed Instamodel 41 and 49 polymer blends were used for the study. Further Instamodel 41 was selected and matrix tablets were further coated with Instacoat EEN to protect drug release in upper GIT. Preliminary trial batches were studied for pre and post compression evaluation test. Formulation showed desirable lag time and dissolution profile were further optimized by applying 32 full factorial design to study the effect of extent of coating (% w/w) Instacoat EEN and Instamodel 41 matrix tablet were selected as independent variables X1 and X2 respectively and two responses as lag time and Cumulative % drug release at 18 hours as Y1 and Y2 respectively. Various kinetic models were applied to the all optimized batches. All F1-F9 and optimized solution batch M results complied with IP standards. The regression equation generated for Lag Time = 9.35- 3.76 A + 0.7533B and for % CDR = +93.93 β 0.9717 A β 4.27 B. The drug release data of optimized formulation were close to that predicted by the model. The formulation M with 5.903 %w/w Instacoat EEN and 125 mg w/w Instamodel 41 was found to be optimum. The present study demonstrates that Methocarbamol enteric coated matrix tablet could be successfully released in lower GIT with delayed action.
PORTABLE BIOPHARMACEUTICAL FORMULATION DEVICE WITH AI INTEGRATION
System developed to determine blood glucose in short period of time easily by anyone without Technical support
Conductivity test apparatus for detection of Emulsion type, temperature and water conductance
An intensive FDP covering advanced HPLC, FTIR, NMR and mass spectrometry techniques for pharmaceutical analysis. 12 faculty members participated.
A practical workshop covering TLC, HPTLC, and microscopic analysis of crude drug samples. 60 students participated under expert guidance.